Diagnocure Inc. (CUR-T) Stock Predictions - Stockchase
WATCH LIST
1
Diagnocure Inc. (CUR-T)

ON STOCKCHASE SINCE Dec 2004

Markets a bladder test for cancer.

biotechnology/pharmaceutical

Diagnocure Inc.

CUR-T

2 watching          
Join the Discussion

Diagnocure Inc. (CUR-T) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

What the experts are saying about CUR-T



  • All
  • Filtered
Signal Opinion Expert
TOP PICK
Diagnocure Inc.(CUR-T) 

December 3, 2004

Has a test on the market for bladder testing for cancer. Now working with a US company, Gen-Probe, to develop a prostrate diagnostic test for the US and world markets. Tests are 90% accurate compared to the PSA tests which are only right once out of four times. Have also just announced testing for lung cancer with high accuracy figures.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Has a test on the market for bladder testing for cancer. Now working with a US company, Gen-Probe, to develop a prostrate diagnostic test for the US and world markets. Tests are 90% accurate compared to the PSA tests which are only right once out of four times. Have also just announced testing for lung cancer with high accuracy figures.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jean-Francois T

Senior Por, Sprott Asset Managem...

Price Price
$5.860
Owned Owned
Yes

Showing 1 to 1 of 1 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days